243
Views
46
CrossRef citations to date
0
Altmetric
Editorial

Microtubule-stabilising drugs for therapy of Alzheimer’s disease and other neurodegenerative disorders with axonal transport impairments

, , &
Pages 683-686 | Published online: 10 May 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sharon M Rymut & Thomas J Kelley. (2015) Broader implications: biological and clinical significance of microtubule acetylation. Cell Health and Cytoskeleton 7, pages 71-82.
Read now
Wei-Shuo Fang & Shao-Rong Wang. (2008) Structural studies of taxol analogues for drug discovery. Expert Opinion on Drug Discovery 3:9, pages 1109-1122.
Read now
Hanno M Roder & Michael L Hutton. (2007) Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease. Expert Opinion on Therapeutic Targets 11:4, pages 435-442.
Read now

Articles from other publishers (43)

Ritesh P. Bhole, Rupesh V. Chikhale & Karishma M. Rathi. (2023) Current Biomarkers and Treatment Strategies in Alzheimer Disease: An Overview and Future Perspectives. IBRO Neuroscience Reports.
Crossref
Christopher Nishioka, Hsiao-Fang Liang, Stephen Ong & Shu-Wei Sun. (2022) Axonal Transport Impairment and its Relationship with Diffusion Tensor Imaging Metrics of a Murine Model of p301L Tau Induced Tauopathy. Neuroscience 498, pages 144-154.
Crossref
Yi-Wei Wang, Liang Wang, Sheng-Jie Yuan, Yuan Zhang, Xin Zhang & Le-Ting Zhou. (2022) Postoperative Cognitive Dysfunction and Alzheimer’s Disease: A Transcriptome-Based Comparison of Animal Models. Frontiers in Aging Neuroscience 14.
Crossref
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, Diraviyam Thirumalai & Balamurugan Palaniappan. (2020) Role of tau protein in Alzheimer's disease: The prime pathological player. International Journal of Biological Macromolecules 163, pages 1599-1617.
Crossref
Chinthalapally V. Rao, Adam S. Asch, Daniel J. J. Carr & Hiroshi Y. Yamada. (2020) “Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease. Aging Cell 19:3.
Crossref
Vidur Sabharwal & Sandhya P. Koushika. (2019) Crowd Control: Effects of Physical Crowding on Cargo Movement in Healthy and Diseased Neurons. Frontiers in Cellular Neuroscience 13.
Crossref
Prasenjit Mondal, Gaurav Das, Juhee Khan, Krishnangsu Pradhan & Surajit Ghosh. (2017) Crafting of Neuroprotective Octapeptide from Taxol-Binding Pocket of β-Tubulin. ACS Chemical Neuroscience 9:3, pages 615-625.
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2017) A critical overview of therapeutic strategy and advancement for Alzheimer's disease treatment. Journal of the Taiwan Institute of Chemical Engineers 77, pages 92-105.
Crossref
Hena Khanam, Abad Ali, Mohd Asif & Shamsuzzaman. (2016) Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review. European Journal of Medicinal Chemistry 124, pages 1121-1141.
Crossref
S. Roy, D.J. Irwin, V.M.-Y. Lee & J.Q. Trojanowski. 2015. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Kevin Lou, Yuemang Yao, Adam T. Hoye, Michael J. James, Anne-Sophie Cornec, Edward Hyde, Bryant Gay, Virginia M.-Y. Lee, John Q. Trojanowski, Amos B. SmithIIIIII, Kurt R. Brunden & Carlo Ballatore. (2014) Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies. Journal of Medicinal Chemistry 57:14, pages 6116-6127.
Crossref
Sara Anna Bonini, Giulia Ferrari-Toninelli, Giuseppina Maccarinelli, Paola Bettinsoli, Mery Montinaro & Maurizio Memo. (2014) Cytoskeletal Protection: Acting on Notch to Prevent Neuronal Dysfunction. Neurodegenerative Diseases 13:2-3, pages 93-95.
Crossref
Ramón Cacabelos, Pablo Cacabelos & Clara Torrellas. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine 563 615 .
Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas, Iván Tellado & Juan C. Carril. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 323 556 .
Sara Anna Bonini, Giulia Ferrari-Toninelli, Mery Montinaro & Maurizio Memo. (2013) Notch signalling in adult neurons: a potential target for microtubule stabilization. Therapeutic Advances in Neurological Disorders 6:6, pages 375-385.
Crossref
Kurt R. Brunden, Nicola M. GardnerMichael J. James, Yuemang Yao, John Q. Trojanowski, Virginia M.-Y. Lee, Ian PatersonCarlo Ballatore & Amos B. SmithIIIIII. (2013) MT-Stabilizer, Dictyostatin, Exhibits Prolonged Brain Retention and Activity: Potential Therapeutic Implications. ACS Medicinal Chemistry Letters 4:9, pages 886-889.
Crossref
S Quraishe, C M Cowan & A Mudher. (2013) NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy. Molecular Psychiatry 18:7, pages 834-842.
Crossref
Oveis Karima, Gholamhossein Riazi, Sirus Khodadadi, Reza Yousefi, Karim Mahnam, Farzad Mokhtari, Tayebe Cheraghi, Elham Hoveizi & Ali Akbar Moosavi-Movahedi. (2012) An in vitro study of the role of β‐boswellic acid in the microtubule assembly dynamics. FEBS Letters 586:23, pages 4132-4138.
Crossref
Carlo Ballatore, Kurt R. Brunden, Donna M. Huryn, John Q. Trojanowski, Virginia M.-Y. Lee & Amos B. SmithIIIIII. (2012) Microtubule Stabilizing Agents as Potential Treatment for Alzheimer’s Disease and Related Neurodegenerative Tauopathies. Journal of Medicinal Chemistry 55:21, pages 8979-8996.
Crossref
Peter W. Baas & Olga I. Mozgova. (2012) A novel role for retrograde transport of microtubules in the axon. Cytoskeleton 69:7, pages 416-425.
Crossref
Gustavo Pigino, Yuyu Song, Laura L. Kirkpatrick & Scott T. Brady. 2012. Basic Neurochemistry. Basic Neurochemistry 101 118 .
Michael VoronkovSteven P BraithwaiteJeffry B Stock. (2011) Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease. Future Medicinal Chemistry 3:7, pages 821-833.
Crossref
Kurt R. Brunden, Yuemang Yao, Justin S. Potuzak, Nuria Ibarz Ferrer, Carlo Ballatore, Michael J. James, Anne-Marie L. Hogan, John Q. Trojanowski, Amos B. SmithIIIIII & Virginia M.-Y. Lee. (2011) The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies. Pharmacological Research 63:4, pages 341-351.
Crossref
Rakez KayedGeorge R. JacksonD. Mark EstesAlan D.T. Barrett. (2011) Alzheimers Disease: Review of Emerging Treatment Role for Intravenous Immunoglobulins. Journal of Central Nervous System Disease 3, pages JCNSD.S5018.
Crossref
Christopher P. Corbo & Alejandra del C. Alonso. 2011. The Brain as a Drug Target. The Brain as a Drug Target 47 83 .
Young-Jung Lee, Sang Bae Han, Sang-Yoon Nam, Ki-Wan Oh & Jin Tae Hong. (2010) Inflammation and Alzheimer’s disease. Archives of Pharmacal Research 33:10, pages 1539-1556.
Crossref
Donald J. AbrahamLone Veng, Mary J. Savage, James C. Barrow & Celina V. Zerbinatti. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 405 446 .
Shaohua Xu, Kurt R. Brunden, John Q. Trojanowski & Virginia M.‐Y. Lee. (2010) Characterization of tau fibrillization in vitro. Alzheimer's & Dementia 6:2, pages 110-117.
Crossref
Alex Crowe, Wenwei Huang, Carlo Ballatore, Ronald L. Johnson, Anne-Marie L. Hogan, Ruili Huang, Jennifer Wichterman, Joshua McCoy, Donna Huryn, Douglas S. Auld, Amos B. SmithIIIIII, James Inglese, John Q. Trojanowski, Christopher P. Austin, Kurt R. Brunden & Virginia M.-Y. Lee. (2009) Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening. Biochemistry 48:32, pages 7732-7745.
Crossref
Mary J. Savage & Diane E. Gingrich. (2009) Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease. Drug Development Research 70:2, pages 125-144.
Crossref
S. Roy, V.M.-Y. Lee & J.Q. Trojanowski. 2009. Encyclopedia of Neuroscience. Encyclopedia of Neuroscience 1199 1203 .
Carlo Ballatore, Bin Zhang, John Q. Trojanowski, Virginia M.-Y. Lee & Amos B. SmithIIIIII. (2008) In situ blood–brain barrier permeability of a C-10 paclitaxel carbamate. Bioorganic & Medicinal Chemistry Letters 18:23, pages 6119-6121.
Crossref
G. Ferrari-Toninelli, S.A. Bonini, P. Bettinsoli, D. Uberti & M. Memo. (2008) Microtubule stabilizing effect of notch activation in primary cortical neurons. Neuroscience 154:3, pages 946-952.
Crossref
Donna M. Barten & Charles F. Albright. (2008) Therapeutic Strategies for Alzheimer’s Disease. Molecular Neurobiology 37:2-3, pages 171-186.
Crossref
Stephan Frank, Florence Clavaguera & Markus Tolnay. (2007) Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathologica 115:1, pages 39-53.
Crossref
Carlo Ballatore, Virginia M.-Y. Lee & John Q. Trojanowski. (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nature Reviews Neuroscience 8:9, pages 663-672.
Crossref
Carlo Ballatore, Edward Hyde, Robert F. Deiches, Virginia M.-Y. Lee, John Q. Trojanowski, Donna Huryn & Amos B. SmithIIIIII. (2007) Paclitaxel C-10 carbamates: Potential candidates for the treatment of neurodegenerative tauopathies. Bioorganic & Medicinal Chemistry Letters 17:13, pages 3642-3646.
Crossref
Alex Crowe, Carlo Ballatore, Edward Hyde, John Q. Trojanowski & Virginia M.-Y. Lee. (2007) High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation. Biochemical and Biophysical Research Communications 358:1, pages 1-6.
Crossref
Vikas Dhikav & Kuljeet Singh Anand. (2007) Glucocorticoids may initiate Alzheimer’s disease: A Potential therapeutic role for mifepristone (RU-486). Medical Hypotheses 68:5, pages 1088-1092.
Crossref
Dale Schenk, Maria C. Carrillo & John Q. Trojanowski. (2006) Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery. Alzheimer's & Dementia 2:4, pages 275-281.
Crossref
Paul A. Wender, Michael K. Hilinski, Philip R. Skaanderup, Nicolas G. Soldermann & Susan L. Mooberry. (2006) Pharmacophore Mapping in the Laulimalide Series:  Total Synthesis of a Vinylogue for a Late-Stage Metathesis Diversification Strategy. Organic Letters 8:18, pages 4105-4108.
Crossref
Gorazd B. StokinLawrence S.B. Goldstein. (2006) Axonal Transport and Alzheimer's Disease. Annual Review of Biochemistry 75:1, pages 607-627.
Crossref
John Q. Trojanowski & Virginia M.-Y. Lee. (2005) The Alzheimer's Brain. The American Journal of Pathology 167:5, pages 1183-1188.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.